We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Company Provides Laboratories with Technologies for Swine Flu Detection

By LabMedica International staff writers
Posted on 14 May 2009
A company that provides innovative life-science solutions, announced that it is providing its technologies to health officials across the globe to aid in the identification of influenza strains, particularly the strain associated with the recent outbreak of the influenzavirus A H1N1, also known as swine flu.

Life Technologies (Gaithersburg, MD, USA), a company created by the combination of Invitrogen Corp. More...
(Carlsbad, CA, USA) and Applied Bios stems, Inc. (Foster City, CA, USA), has formed a special 24-hour-a-day task force across key business units to coordinate the company-wide response to global requests for assistance with the outbreak. The task force is leading efforts to provide health agencies with front-line support such as instrument training, managing the supply chain to ensure that products get to customers as quickly as possible, and ensuring appropriate regulatory compliance. Life Technologies is also accelerating the manufacture of components that will be used by laboratories to test for and identify influenza.

Through its Invitrogen and Applied Biosystems brands, Life Technologies offers components that support the workflow surrounding the identification of influenza virus strains. The company's products include the MagMAX viral RNA isolation kits for RNA purification; the SuperScript III; Platinum One-Step reverse transcriptase- polymerase chain reaction (qRT-PCR) kit for amplification of viral RNA; TaqMan Influenza A detection kit 2.0 for initial influenza type A screening; and several different capillary electrophoresis systems for determining the base-by-base sequence of viral samples. Additionally, the company offers its 7500 Fast and Fast Dx Real-Time PCR instruments under the Applied Biosystems brand.

"The spread of this new virus illustrates the importance of strong global surveillance programs," said Mark Stevenson, president and COO for Life Technologies. "Our technologies continue to be essential tools for public health agencies as they shift from reacting to the emergence of a potentially pandemic flu strain to proactively monitoring populations to identify the new strain as it arises."

Life Technologies is a global biotechnology tools company focused on improving the human condition. Life Technologies' customers do their work across the biologic spectrum, working to advance personalized medicine, molecular diagnostics, regenerative science, agricultural and environmental research, and 21st century forensics.

Related Links:
Life Technologies



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.